Co-infections. Predicting recovery from hep C.
D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use; D019562:Viral Load
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons